Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis

por Greasley, Peter J., Bonnard, Claude, Amati, Bruno
Publicado 2000

Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation

por Bjursell, Mikael, Ryberg, Erik, Wu, Tingting, Greasley, Peter J., Bohlooly-Y, Mohammad, Hjorth, Stephan
Publicado en PLoS One (2016)

Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function

por Petrykiv, Sergei, Sjöström, C. David, Greasley, Peter J., Xu, John, Persson, Frederik, Heerspink, Hiddo J.L.
Publicado en Clin J Am Soc Nephrol (2017)

Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data

por Hallow, K. Melissa, Greasley, Peter J., Helmlinger, Gabriel, Chu, Lulu, Heerspink, Hiddo J., Boulton, David W.
Publicado en Am J Physiol Renal Physiol (2018)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia

por Block, Geoffrey A, Rosenbaum, David P, Yan, Andrew, Greasley, Peter J, Chertow, Glenn M, Wolf, Myles
Publicado en Nephrol Dial Transplant (2019)

Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes

por Cabrera, Claudia S., Lee, Alison S., Olsson, Marita, Schnecke, Volker, Westman, Klara, Lind, Marcus, Greasley, Peter J., Skrtic, Stanko
Publicado en Kidney Int Rep (2020)

Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus

por Go, Alan S., Yang, Jingrong, Tan, Thida C., Cabrera, Claudia S., Stefansson, Bergur V., Greasley, Peter J., Ordonez, Juan D.
Publicado en BMC Nephrol (2018)

N-arachidonoyl--serine is neuroprotective after traumatic brain injury by reducing apoptosis

por Cohen-Yeshurun, Ayelet, Trembovler, Victoria, Alexandrovich, Alexander, Ryberg, Erik, Greasley, Peter J, Mechoulam, Raphael, Shohami, Esther, Leker, Ronen R
Publicado 2011

A common NHE3 single-nucleotide polymorphism has normal function and sensitivity to regulatory ligands

por Yin, Jianyi, Tse, Chung-Ming, Cha, Boyoung, Sarker, Rafiquel, Zhu, Xinjun C., Walentinsson, Anna, Greasley, Peter J., Donowitz, Mark
Publicado en Am J Physiol Gastrointest Liver Physiol (2017)

Effects of the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes

por Dekkers, Claire C. J., Sjöström, C. David, Greasley, Peter J., Cain, Valerie, Boulton, David W., Heerspink, Hiddo J. L.
Publicado en Diabetes Obes Metab (2019)

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

por Whyte, Lauren S., Ryberg, Erik, Sims, Natalie A., Ridge, Susan A., Mackie, Ken, Greasley, Peter J., Ross, Ruth A., Rogers, Michael J.
Publicado 2009

Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling

por Sokolov, Victor, Yakovleva, Tatiana, Chu, Lulu, Tang, Weifeng, Greasley, Peter J., Johansson, Susanne, Peskov, Kirill, Helmlinger, Gabriel, Boulton, David W., Penland, Robert C.
Publicado en CPT Pharmacometrics Syst Pharmacol (2020)

Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion

por Karlsson, Cecilia, Wallenius, Kristina, Walentinsson, Anna, Greasley, Peter J, Miliotis, Tasso, Hammar, Mårten, Iaconelli, Amerigo, Tapani, Sofia, Raffaelli, Marco, Mingrone, Geltrude, Carlsson, Björn
Publicado en J Clin Endocrinol Metab (2020)

Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline

por Stefánsson, Bergur V., Heerspink, Hiddo J.L., Wheeler, David C., Sjöström, C. David, Greasley, Peter J., Sartipy, Peter, Cain, Valerie, Correa-Rotter, Ricardo
Publicado en Data Brief (2021)

Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach

por Walsh, Sarah K, Hepburn, Claire Y, Keown, Oliver, Åstrand, Annika, Lindblom, Anna, Ryberg, Erik, Hjorth, Stephan, Leslie, Stephan J, Greasley, Peter J, Wainwright, Cherry L
Publicado en Pharmacol Res Perspect (2015)

A metabolomics‐based molecular pathway analysis of how the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes...

por Mulder, Skander, Hammarstedt, Ann, Nagaraj, Sunil B., Nair, Viji, Ju, Wenjun, Hedberg, Jonatan, Greasley, Peter J., Eriksson, Jan W., Oscarsson, Jan, Heerspink, Hiddo J. L.
Publicado en Diabetes Obes Metab (2020)

Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects

por Westergren, Helena U., Svedlund, Sara, Momo, Remi A., Blomster, Juuso I., Wåhlander, Karin, Rehnström, Erika, Greasley, Peter J., Fritsche-Danielson, Regina, Oscarsson, Jan, Gan, Li-Ming
Publicado en Cardiovasc Diabetol (2016)

Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis

por Block, Geoffrey A., Rosenbaum, David P., Leonsson-Zachrisson, Maria, Stefansson, Bergur V., Rydén-Bergsten, Tina, Greasley, Peter J., Johansson, Susanne A., Knutsson, Mikael, Carlsson, Björn C.
Publicado en Clin J Am Soc Nephrol (2016)

Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19

por Fisk, Marie, Althage, Magnus, Moosmang, Sven, Greasley, Peter J., Cope, Andrew P., Jayne, David RW., Galloway, James, Hall, Frances, Wilkinson, Ian B., Ambery, Philip, Cheriyan, Joseph
Publicado en Pulm Pharmacol Ther (2021)

Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study

por Whittaker, Andrew, Kragh, Åsa M., Hartleib‐Geschwindner, Judith, Albayaty, Muna, Backlund, Anna, Greasley, Peter J., Heijer, Maria, Kjaer, Magnus, Forte, Pablo, Unwin, Robert, Wernevik, Linda, Ericsson, Hans
Publicado en Clin Transl Sci (2019)